Irish Medical TimesGood prospects for long-term remissionIrish Medical TimesRituximab acts by depletion of B cells. Rituximab should be used in combination with methotrexate (NICE 2010). Other therapies include abatacept and tocilizumab. X-rays often s…

Severe Vasculitis Yields to RituximabMedPage TodayOne small study documented that rituximab was very effective and well-tolerated therapy for HCV-associated cryoglobulinemic vasculitis in patients in whom antiviral therapy had failed to induce remissio…

Online psychotherapy treats teenagers with chronic fatigue syndrome (CFS)Active QuoteCancer drug Rituximab has also recently been shown to successfully treat the symptoms of chronic fatigue syndrome (CFS). Compare health insurance quotes online now to …

No help for parents of brave little battler Max ValentineHerald SunAfter his stroke, Max had platelet and blood transfusions for five weeks and the experimental treatment rituximab, given to him through four infusions at the Royal Children's Hospit…

Immune Response Markers for Cancer Vaccines Paint a Clearer PictureGenetic Engineering NewsStudy results showed that BiovaxID active immunotherapy following treatment with rituximab combination chemotherapy induced nearly universal immune responses. Th…

COMPUGEN LTD. : Compugen Presents Prediction Based Discovery Strategy4-traders… within the infrastructure and has resulted to date in multiple discoveries, such as the previously disclosed CGEN-928 with potential use for late stage, aggressive and dr…

Compugen Presents Prediction Based Discovery Strategy At “Targets And …TheStreet.com (press release)… within the infrastructure and has resulted to date in multiple discoveries, such as the previously disclosed CGEN-928 with potential use for lat…

Compugen Presents Prediction Based Discovery Strategy at "Targets and …MarketWatch (press release)… within the infrastructure and has resulted to date in multiple discoveries, such as the previously disclosed CGEN-928 with potential use for la…

USA TODAYNICE recommends earlier use of Roche's RoActemra for rheumatoid arthritisPMLiVE… for people with RA as a third-line treatment option if DMARDs had been ineffective, and if patients had also both demonstrated an inadequate response to one…

Pixantrone Progresses Toward Approval in the European UnionMedscapeIn addition, the CHMP noted that the benefit of pixantrone appeared to be lower in patients who had used rituximab in the past, and that its benefit was not established when used as a f…